Open access · CC-BY
via OpenAlex
New Insight into Metformin Mechanism of Action and Clinical Application
Yun Yan, Karen L. Kover, Wayne V. Moore
IntechOpen eBooks · 2020 · ▲ 11 citations
Abstract
Metformin is the first-line medication for Type 2 diabetes (T2D) treatment, and it is the only US FDA approved oral antidiabetic medication for pediatric patients with T2D 10 years and older. Metformin is also used to treat polycystic ovary syndrome (PCOS), another condition with underlying insulin resistance. The clinical applications of metformin are continuing to expand into other fields including cancer, aging, cardiovascular diseases, and neurodegenerative diseases. Metformin modulates multiple biological pathways. Its novel properties and effects continue to evolve; however, its molecular mechanism of action remains incompletely understood. In this chapter, we focus on the recent translational research and clinical data on the molecular action of metformin and the evidence linking the effects of metformin on insulin resistance, prediabetes, diabetes, aging, cancer, PCOS, cardiovascular diseases, and neurodegenerative diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5772/intechopen.91148
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Yan, Y., Kover, K.L., & Moore, W.V. (2020). New Insight into Metformin Mechanism of Action and Clinical Application. <em>IntechOpen eBooks</em>. https://doi.org/10.5772/intechopen.91148
Vancouver
Yan Y, Kover KL, Moore WV. New Insight into Metformin Mechanism of Action and Clinical Application. IntechOpen eBooks. 2020. doi:10.5772/intechopen.91148.
BibTeX
@article{yun2020NewIns,
title = {New Insight into Metformin Mechanism of Action and Clinical Application},
author = {Yun Yan and Karen L. Kover and Wayne V. Moore},
journal = {IntechOpen eBooks},
year = {2020},
doi = {10.5772/intechopen.91148},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Endocrinology 2021
Open access · CC-BY
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Metabolism 2022
Open access · CC-BY
Metformin: Is it a drug for all reasons and diseases?
eLife 2017
Open access · CC-BY
Metformin extends C. elegans lifespan through lysosomal pathway
Pharmaceuticals 2023
Open access · CC-BY
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
World Journal of Stem Cells 2020
Open access · CC-BY
Effect of metformin on stem cells: Molecular mechanism and clinical prospect
International Journal of Research in Pharmacology & Pharmacotherapeutics 2025
Open access · OA